BAX vs BDX: fair value comparison
Baxter International Inc. and Becton, Dickinson and Company · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, BDX currently sits closer to the top of our discount ranking. BDX carries the stronger quality grade.
| BAX | BDX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.80 | $177.85 |
| 12-month range | $16.78–$28.10 | $145.33–$201.91 |
| Sector rank | #54 of 113 Healthcare | #50 of 113 Healthcare |
| Quality grade | F | D |
| Leverage | High | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Declining |
| RSI zone | Oversold | Neutral |
| DCF cross-check | Overvalued | Undervalued |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: BAX fair value analysis · BDX fair value analysis